SE9504537D0 - Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet - Google Patents

Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet

Info

Publication number
SE9504537D0
SE9504537D0 SE9504537A SE9504537A SE9504537D0 SE 9504537 D0 SE9504537 D0 SE 9504537D0 SE 9504537 A SE9504537 A SE 9504537A SE 9504537 A SE9504537 A SE 9504537A SE 9504537 D0 SE9504537 D0 SE 9504537D0
Authority
SE
Sweden
Prior art keywords
pct
treating
ways
during sleep
respiratory disorders
Prior art date
Application number
SE9504537A
Other languages
English (en)
Swedish (sv)
Inventor
Jan Hedner
Holger Kraiczi
Original Assignee
Jan Hedner
Holger Kraiczi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Holger Kraiczi filed Critical Jan Hedner
Priority to SE9504537A priority Critical patent/SE9504537D0/xx
Publication of SE9504537D0 publication Critical patent/SE9504537D0/xx
Priority to JP52271097A priority patent/JP3756193B2/ja
Priority to DK96943443T priority patent/DK0923370T3/da
Priority to AT96943443T priority patent/ATE309795T1/de
Priority to AU12176/97A priority patent/AU701911B2/en
Priority to EP96943443A priority patent/EP0923370B1/fr
Priority to US09/091,382 priority patent/US6034117A/en
Priority to ES96943443T priority patent/ES2256865T3/es
Priority to PCT/SE1996/001677 priority patent/WO1997022339A1/fr
Priority to CA002240717A priority patent/CA2240717C/fr
Priority to DE69635459T priority patent/DE69635459T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
SE9504537A 1995-12-19 1995-12-19 Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet SE9504537D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9504537A SE9504537D0 (sv) 1995-12-19 1995-12-19 Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
DE69635459T DE69635459T2 (de) 1995-12-19 1996-12-17 Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes
AU12176/97A AU701911B2 (en) 1995-12-19 1996-12-17 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
DK96943443T DK0923370T3 (da) 1995-12-19 1996-12-17 Acetylcholinesteraseinhibitorer til behandling og diagnosticering af sövnrelaterede respirationsforstyrrelser
AT96943443T ATE309795T1 (de) 1995-12-19 1996-12-17 Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes
JP52271097A JP3756193B2 (ja) 1995-12-19 1996-12-17 睡眠時呼吸障害を治療および診断する方法、並びにこの方法を実施する手段
EP96943443A EP0923370B1 (fr) 1995-12-19 1996-12-17 Inhibiteurs de l'acetylcholine esterase pour diagnostiquer et traiter des troubles de la respiration pendant le sommeil
US09/091,382 US6034117A (en) 1995-12-19 1996-12-17 Methods of treating and diagnosing sleep disordered breathing and means for carrying out the method
ES96943443T ES2256865T3 (es) 1995-12-19 1996-12-17 Inhibidores de acetil colina esterasa para tratar y diagnosticar desordenes en la respiracion durante el sueño.
PCT/SE1996/001677 WO1997022339A1 (fr) 1995-12-19 1996-12-17 Methode de diagnostic et de traitement des troubles de la respiration pendant le sommeil et dispositif de mise en oeuvre de cette methode
CA002240717A CA2240717C (fr) 1995-12-19 1996-12-17 Methode de diagnostic et de traitement des troubles de la respiration pendant le sommeil et dispositif de mise en oeuvre de cette methode

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504537A SE9504537D0 (sv) 1995-12-19 1995-12-19 Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet

Publications (1)

Publication Number Publication Date
SE9504537D0 true SE9504537D0 (sv) 1995-12-19

Family

ID=20400641

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9504537A SE9504537D0 (sv) 1995-12-19 1995-12-19 Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet

Country Status (11)

Country Link
US (1) US6034117A (fr)
EP (1) EP0923370B1 (fr)
JP (1) JP3756193B2 (fr)
AT (1) ATE309795T1 (fr)
AU (1) AU701911B2 (fr)
CA (1) CA2240717C (fr)
DE (1) DE69635459T2 (fr)
DK (1) DK0923370T3 (fr)
ES (1) ES2256865T3 (fr)
SE (1) SE9504537D0 (fr)
WO (1) WO1997022339A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289816T1 (de) * 1997-11-14 2005-03-15 Akzo Nobel Nv Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
US6352715B1 (en) * 1998-02-19 2002-03-05 Sagittarius Life Science Corp Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease
US6262081B1 (en) * 1998-07-10 2001-07-17 Dupont Pharmaceuticals Company Composition for and method of treating neurological disorders
DE19856897A1 (de) * 1998-12-10 2000-06-15 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum zur Unterdrückung von Schnarchgeräuschen
OA11740A (en) * 1998-12-24 2005-05-13 Janssen Pharmaceutica Nv Controlled release galantamine composition.
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US20070173893A1 (en) * 2000-10-20 2007-07-26 Pitts Walter C Method and apparatus for preventing obstructive sleep apnea
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
CN1194688C (zh) * 2001-07-03 2005-03-30 山东绿叶制药股份有限公司 石杉碱甲及其衍生物或其盐的注射用缓释微球及其制备方法
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
WO2004041281A1 (fr) * 2002-11-01 2004-05-21 Oregon Health And Science University Traitement du trouble hyperkinetique avec du donepezil
US20040266659A1 (en) * 2003-06-27 2004-12-30 Stephen LaBerge Substances that enhance recall and lucidity during dreaming
WO2005016327A2 (fr) * 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Traitement de troubles du sommeil a l'aide d'inhibiteurs de la cholinesterase
WO2005042475A2 (fr) 2003-10-21 2005-05-12 Sention, Inc. Esters de carbamoyle inhibant la cholinesterase et liberant des agents pharmacologiquement actifs
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
JP2010518010A (ja) 2007-02-02 2010-05-27 コルシド・ファーマシューティカルズ・インコーポレイテッド コリンエステラーゼを阻害する化合物
US20090048229A1 (en) * 2007-07-18 2009-02-19 Rupniak Nadia M J Methods for promoting wakefulness
EP2251010A1 (fr) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Utilisation de tiabendazole et dérivés correspondants pour la thérapie de conditions neurologiques
US8753327B2 (en) 2011-01-28 2014-06-17 Pfantastic Medical Research Institute, Llc Methods for treating obstructive sleep apnea
US9642841B1 (en) 2014-03-14 2017-05-09 James M. Hand Snoring treatment
JP6526475B2 (ja) * 2015-04-30 2019-06-05 サンスター株式会社 経皮唾液腺投与用の唾液分泌促進剤
JP6514420B2 (ja) 2016-05-11 2019-05-15 ヘドナー，ヤン 睡眠時無呼吸の処置のためのスルチアム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
DE4115558A1 (de) * 1991-05-13 1992-11-19 Dresden Arzneimittel Prophylaktisches antidot gegen phosphororganische gifte
NZ242744A (en) * 1991-05-14 1997-02-24 Ernir Snorrason Use of a cholinesterase inhibitor (eg a galanthamine derivative) for treating fatigue
DE19548812A1 (de) * 1995-12-27 1997-07-03 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation

Also Published As

Publication number Publication date
ATE309795T1 (de) 2005-12-15
EP0923370B1 (fr) 2005-11-16
DE69635459T2 (de) 2006-08-03
CA2240717A1 (fr) 1997-06-26
ES2256865T3 (es) 2006-07-16
DE69635459D1 (de) 2005-12-22
EP0923370A2 (fr) 1999-06-23
CA2240717C (fr) 2002-11-26
JP3756193B2 (ja) 2006-03-15
JP2000511873A (ja) 2000-09-12
US6034117A (en) 2000-03-07
AU701911B2 (en) 1999-02-11
AU1217697A (en) 1997-07-14
WO1997022339A1 (fr) 1997-06-26
DK0923370T3 (da) 2006-03-27

Similar Documents

Publication Publication Date Title
SE9504537D0 (sv) Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
DK0728006T3 (da) Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser
FI964332A0 (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
DE69616333D1 (de) Thip zur behandlung von schlafstörungen
DE69924869D1 (de) Medikament zur behandlung chronisch obstruktiver lungenerkrankung
UA29451C2 (uk) Спосіб збереження або збільшення щільності кістки або інгібування втрати кісткової маси
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
ATE169225T1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
BG104654A (en) Method for treatment of chronic obstructive pulmonary disease (copd)
ATE213634T1 (de) Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts
MY124089A (en) Use of cetirizine for preventing the onset of asthma
HRP20080389A2 (en) THE USE OF R(+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL FOR THE TREATMENT OF SLEEP DISORDERS
JO2127B1 (en) How to prevent asthma
EE03488B1 (et) Meetod anhüdroekgoniini estrite valmistamiseks
CA2197869A1 (fr) Agent therapeutique pour maladies du cartilage
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.
SE9903085L (sv) Användning av åtminstone ett nikotinbaserat ämne och/eller ett ur detta ämne framställt ämne för tillverkning av ett medikament
UA33683A (uk) Спосіб лікування поліпозного риносинуїту